16387998|t|Emergent complications following donepezil switchover to galantamine in three cases of dementia with Lewy bodies.
16387998|a|Delayed disease progression and symptomatic improvement occur with cholinesterase inhibitors (ChEIs) in dementia with Lewy bodies (DLB). In this study, complications (insomnia, dyskinesias, agitation, and delirium) occurred in three patients switched from donepezil to galantamine. The authors describe evidence-based recommendations for ChEI switchover in DLB.
16387998	33	42	donepezil	Chemical	MESH:D000077265
16387998	57	68	galantamine	Chemical	MESH:D005702
16387998	87	112	dementia with Lewy bodies	Disease	MESH:D020961
16387998	218	243	dementia with Lewy bodies	Disease	MESH:D020961
16387998	245	248	DLB	Disease	MESH:D020961
16387998	281	289	insomnia	Disease	MESH:D007319
16387998	291	302	dyskinesias	Disease	MESH:D004409
16387998	304	313	agitation	Disease	MESH:D011595
16387998	319	327	delirium	Disease	MESH:D003693
16387998	347	355	patients	Species	9606
16387998	370	379	donepezil	Chemical	MESH:D000077265
16387998	383	394	galantamine	Chemical	MESH:D005702
16387998	471	474	DLB	Disease	MESH:D020961
16387998	Positive_Correlation	MESH:D000077265	MESH:D003693
16387998	Negative_Correlation	MESH:D000077265	MESH:D020961
16387998	Positive_Correlation	MESH:D005702	MESH:D007319
16387998	Positive_Correlation	MESH:D005702	MESH:D003693
16387998	Positive_Correlation	MESH:D000077265	MESH:D011595
16387998	Positive_Correlation	MESH:D000077265	MESH:D004409
16387998	Positive_Correlation	MESH:D005702	MESH:D011595
16387998	Comparison	MESH:D000077265	MESH:D005702
16387998	Positive_Correlation	MESH:D000077265	MESH:D007319
16387998	Positive_Correlation	MESH:D005702	MESH:D004409
16387998	Negative_Correlation	MESH:D005702	MESH:D020961

